abs244.txt	historically		through	the	conduct	of	prospective	clinical	trials	breast	cancersurgeons	have	performed	less	radical	and	axillary	surgeries	with	nosurvival	decrement	to	our	patients	currently	other	opportunities	exist	for	thetreating	surgeon	do	possibilities	include	active	surveillance	forductal	carcinoma	in	situ	ablative	therapy	small	primary	cancers	selective	omission	a	sentinel	node	biopsy	elimination	breastsurgery	after	neoadjuvant	systemic	surgeons	must	be	leaders	inthe	development	testing	effective	least	interventionpossible
